RetractedArticleCancer gene therapy2022

Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer.

Donge Tang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.